(NASDAQ: TMCI) Treace Medical Concepts's forecast annual revenue growth rate of 9.3% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.56%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.43%.
Treace Medical Concepts's revenue in 2025 is $209,357,000.On average, 4 Wall Street analysts forecast TMCI's revenue for 2025 to be $14,242,190,670, with the lowest TMCI revenue forecast at $14,211,319,639, and the highest TMCI revenue forecast at $14,329,794,266. On average, 4 Wall Street analysts forecast TMCI's revenue for 2026 to be $15,643,848,211, with the lowest TMCI revenue forecast at $15,347,849,498, and the highest TMCI revenue forecast at $16,115,555,066.
In 2027, TMCI is forecast to generate $17,096,289,537 in revenue, with the lowest revenue forecast at $16,537,605,273 and the highest revenue forecast at $17,699,120,003.